More Business Wire
View Older Stories View Newer Stories-
NMDP and CIBMTR to Present New, Promising Stem Cell Transplantation Trial Data using Mismatched, Unrelated Donors at 2024 ASCO Annual Meeting
-
Iambic Therapeutics Announces Poster Presentation for IAM1363, a Clinical Stage Type II HER2 Inhibitor, at the 2024 ASCO Annual Meeting
-
Genmab to Showcase Data in Various Patient Populations to be Presented at the American Society of Clinical Oncology (ASCO) Annual Meeting
-
SOTIO Presents Overview of DUET-01 Phase 1/2 Study at ASCO Annual Meeting
-
Legend Biotech to Highlight Leadership in CAR-T Cell Therapy for Patients with Multiple Myeloma at ASCO and EHA
-
Orca Bio to Present Positive Clinical Outcomes with Orca-T in Patients with AML at 2024 ASCO Annual Meeting
-
Xspray to present data at ASCO highlighting frequent comedication of PPIs with TKIs in CML-patients and greater than expected negative effects on the bioavailability of crystalline dasatinib
-
City of Hope Researchers to Present Investigational Treatments for Colorectal, Kidney and Blood Cancers at 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
-
Obsidian Therapeutics Announces Positive Clinical Data from OBX-115 in Patients with Advanced Melanoma at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
-
Comvest Partners Announces $70 Million Senior Credit Facility For Nationwide Energy Partners to Support Growth Strategy
-
EMD Serono to Showcase Advances in the Science of Cancer With New Data Presented at ASCO 2024
-
NeraCare Announces Publication of Abstract on Clinical Validation of a Prognostic 7-Biomarker Assay for Prediction of Relapse in Patients with Early-Stage Cutaneous Melanoma at the 2024 American Socie
-
AffyImmune Announces Confirmed Complete Response in Patient with Anaplastic Thyroid Cancer
-
Menarini Group Presents Updated Data from ELECTRA and ELEVATE Combination Studies of Elacestrant (ORSERDU®) in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the ASCO 2024 Annual Meeting
-
Incendia Therapeutics Announces Upcoming Presentation with PathAI at the 2024 American Society of Clinical Oncology Annual Meeting
-
Klaviyo to Present at the William Blair Growth Stock Conference
-
Dentalcorp Announces Annual General Meeting Voting Results
-
Ligand to Participate in Upcoming Investor Conferences
-
Genworth Financial Announces Results of Annual Meeting
-
Phreesia’s Amy Patel Named One of PM360’s 2024 ELITE 100
-
Alerus Financial Corporation Declares Cash Dividend on Common Shares
-
Enhabit Provides Additional Details on Robust Strategic Review Process
-
Lincoln National Corporation's Board of Directors Declares Quarterly Cash Dividend
-
Caleres Declares Regular Quarterly Dividend
-
Stevanato Group to Present at Upcoming Investor Conferences
-
Sallie Mae CFO to Speak at TD Financial Services & Fintech Summit
-
Secret Creek Fish Passage Project Nets Granite $48 Million Contract in Snohomish County, Washington
-
Hecla Announces Leadership Transition
-
On Elects Laura Miele as a New Independent Member of the Board of Directors
-
Terra and Grass River Awarded WiredScore Platinum Certification with a Smart Home Designation at Grove Central in Miami, FL
-
AM Best Downgrades Issuer Credit Ratings of Lumico Life Insurance Group Members; Places Credit Ratings Under Review With Negative Implications
-
SatixFy Announces First Quarter 2024 Results
-
ProAssurance Announces Election of Richard J. Bielen, C.P.A., and Staci M. Pierce, J.D., to Board
-
AM Best Places Credit Ratings of iptiQ Life S.A. Under Review with Negative Implications
-
Materna Medical Completes First Close of Series B2 Financing Round
-
Cadence’s Anirudh Devgan to Present at Bernstein Conference
-
American Tower Corporation Declares Quarterly Distribution
-
Bio-Rad’s Management to Participate in Fireside Chat During Jefferies Global Healthcare Conference
-
Equitable Holdings to Participate in the 2024 Morgan Stanley US Financials, Payments and CRE Conference
-
Baxter to Present at Jefferies 2024 Global Healthcare Conference
-
Liberty Broadband Corporation Declares Quarterly Cash Dividend on Series A Cumulative Redeemable Preferred Stock
-
Office Properties Income Trust Announces Additional Amendments to Private Exchange Offers Relating to Existing Unsecured Senior Notes
-
XAI Octagon Floating Rate & Alternative Income Trust Will Host Q1 2024 Quarterly Webinar on May 30, 2024
-
WisdomTree Publishes Presentation Highlighting Company’s Track Record of Success and Strategic Momentum Ahead of 2024 Annual Meeting of Stockholders
-
Belden Declares Quarterly Dividend
-
Cross Country Healthcare to Attend Citizens JMP Medical Devices and Healthcare Services Forum
-
Eagle Materials Declares Quarterly Dividend
-
Assurant Board of Directors Declares Quarterly Dividend of $0.72 per Common Share
-
Heuron Gets FDA Green Light for Stroke Triage and Notification Solution
-
LuxUrban Hotels Announces Closing of Public Offering of Securities

